{"id":737411,"date":"2026-08-29T18:53:36","date_gmt":"2026-08-29T18:53:36","guid":{"rendered":"https:\/\/www.europesays.com\/es\/737411\/"},"modified":"2026-08-29T18:53:36","modified_gmt":"2026-08-29T18:53:36","slug":"datos-de-novartis-en-el-congreso-esc-2026-refuerzan-su-liderazgo-cardiovascular","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/es\/737411\/","title":{"rendered":"Datos de\u00a0Novartis en el Congreso ESC 2026 refuerzan su liderazgo cardiovascular\u00a0"},"content":{"rendered":"<p class=\"mostrar_fragmento\">Novartis presentar\u00e1 datos de 10 abstracts de su portafolio cardiovascular en el Congreso de la Sociedad Europea de Cardiolog\u00eda (ESC) 2026, reforzando su liderazgo en el abordaje del riesgo cardiovascular.\u00bbLos datos que presentamos en el ESC de este a\u00f1o refuerzan nuestro compromiso con el avance de la ciencia en el \u00e1mbito cardiovascular para aquellos &#8230;            &#13;\n        <\/p>\n<p> &#13;<\/p>\n<p class=\"MsoNormal\">Novartis presentar\u00e1 datos de 10 abstracts de su portafolio&#13;<br \/>\ncardiovascular en el <strong>Congreso de la Sociedad Europea de Cardiolog\u00eda (ESC) 2026<\/strong>,&#13;<br \/>\nreforzando su liderazgo en el abordaje del riesgo cardiovascular.<\/p>\n<p class=\"MsoNormal\">\u00abLos datos que presentamos en el ESC de este a\u00f1o&#13;<br \/>\nrefuerzan nuestro compromiso con el avance de la ciencia en el \u00e1mbito&#13;<br \/>\ncardiovascular para aquellos pacientes que siguen estando en riesgo de sufrir&#13;<br \/>\nun futuro evento cardiovascular, a pesar de los tratamientos actuales\u00bb,&#13;<br \/>\nse\u00f1al\u00f3 la <strong>Dra. Ruchira Glaser, M.D, Directora Global de la unidad de Desarrollo&#13;<br \/>\nCardiovascular, Renal y Metab\u00f3lico de Novartis<\/strong>. <\/p>\n<p class=\"MsoNormal\">\u00abDesde medicamentos ya&#13;<br \/>\nconsolidados hasta terapias innovadoras en investigaci\u00f3n, nuestro portafolio&#13;<br \/>\nrefleja nuestro compromiso con abordar los desaf\u00edos persistentes en la atenci\u00f3n&#13;<br \/>\ncardiovascular\u00bb.<\/p>\n<p> &#13;<\/p>\n<p class=\"MsoNormal\">\u00a0<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/es\/wp-content\/uploads\/2026\/08\/immedicohospitalario_datos_denovartis_congreso__57706_24134722.png\" width=\"893\" height=\"359\"\/><\/p>\n<p><\/p>\n<p>&#13;<br \/>\n            SEGUIR LEYENDO&#13;\n        <\/p>\n","protected":false},"excerpt":{"rendered":"Novartis presentar\u00e1 datos de 10 abstracts de su portafolio cardiovascular en el Congreso de la Sociedad Europea de&hellip;\n","protected":false},"author":2,"featured_media":737412,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[92],"tags":[130896,1705,33449,130893,130895,19531,11866,56,130892,20893,25,37706,24,1292,33448,165,130897,47798,15562,5024,1817,318,21791,1516,166,32746,11386,23,3271,130894],"class_list":["post-737411","post","type-post","status-publish","format-standard","has-post-thumbnail","category-salud","tag-abelacimab","tag-analisis","tag-auricular","tag-azalea","tag-caracterizando","tag-cardiovascular","tag-congreso","tag-datos","tag-de-novartis","tag-episodios","tag-es","tag-esc","tag-espana","tag-estudio","tag-fibrilacion","tag-health","tag-hemorragicos","tag-incluyendo","tag-liderazgo","tag-nuevos","tag-pacientes","tag-perfil","tag-recurrentes","tag-refuerzan","tag-salud","tag-sangrado","tag-seguiran","tag-spain","tag-su","tag-timi"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@es\/117180315652494407","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/737411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/comments?post=737411"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/737411\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media\/737412"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media?parent=737411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/categories?post=737411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/tags?post=737411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}